Detalhe da pesquisa
1.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Cell
; 183(2): 363-376.e13, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007267
2.
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer.
Immunity
; 56(1): 93-106.e6, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574773
3.
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.
Cell
; 170(2): 352-366.e13, 2017 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28709002
4.
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
Immunity
; 54(3): 586-602.e8, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691136
5.
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8004): 646-655, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418879
6.
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Cell
; 159(3): 499-513, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25417103
7.
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity.
Nature
; 611(7934): 148-154, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171287
8.
Integrating genomic features for non-invasive early lung cancer detection.
Nature
; 580(7802): 245-251, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269342
9.
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy.
J Pathol
; 263(2): 190-202, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525811
10.
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8005): E11, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480897
11.
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816613
12.
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.
Mol Cancer
; 18(1): 32, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823926
13.
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Cancer Cell
; 42(3): 429-443.e4, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366589
14.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Lung Cancer
; 186: 107418, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931445
15.
Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
Cancer Res
; 82(16): 2838-2847, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748739
16.
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer.
Cancer Cell
; 40(3): 289-300.e4, 2022 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216676
17.
Inferring gene expression from cell-free DNA fragmentation profiles.
Nat Biotechnol
; 40(4): 585-597, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361996
18.
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease.
Cancer Discov
; 11(12): 2968-2986, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785539
19.
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Cancer Cell
; 39(10): 1422-1437.e10, 2021 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597589
20.
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma.
J Clin Oncol
; 39(23): 2605-2616, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909455